Japan

Chugai Matsunage plant circa 1943
Biotech

JPM26: Chugai chases new science and name recognition

Chugai's leaders feel that its drugs, like blockbuster Hemlibra and buzzy orforglipron, have become more recognizable than the company that made them.
Darren Incorvaia Jan 16, 2026 5:28am
graphic art of a right hand signing something

Hansoh, Chugai ink separate and lucrative licensing agreements

Oct 17, 2025 11:04am
A ballpoint pen rests on top of a stack of documents ready for signing

Kyorin pens $105M pact for Japan rights to Hinge's lupus drug

Oct 1, 2025 6:40am
A close-up view of a jigsaw puzzle with a missing piece

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am
GE Healthcare Building

Lantheus taps GE HealthCare to sell its PSMA PET tracer in Japan

Sep 24, 2025 11:30am
RNA Concept 3D Render

Japan biotech inks RNA research pact that includes mRNA compounds

Sep 19, 2025 10:49am